Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial

NCT04847661 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Mefloquine as a prophylaxis against SARS-Cov-2 infection in household contacts of COVID 19 confirmed cases

Sponsor

Helwan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]